Related Experiment Video

Updated: Aug 14, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Update on community-acquired pneumonia. New pathogens and new concepts in treatment

Lionel A Mandell1

  • 1Division of Infectious Diseases, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada. lmandell@mcmaster.ca

Postgraduate Medicine
|November 22, 2005
PubMed

Insights

New antibiotics and pathogens are emerging for community-acquired pneumonia (CAP). This expert review discusses treatment guidelines, therapy choices, and strategies to combat antimicrobial resistance.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Antimicrobial Stewardship

Background:

  • Emergence of novel pathogens causing community-acquired pneumonia (CAP).
  • Development of new antibiotic agents to address evolving microbial threats.
  • Need for updated clinical guidelines in managing CAP.

Purpose of the Study:

  • Provide an expert perspective on recent advancements in CAP.
  • Analyze current treatment guidelines for community-acquired pneumonia.
  • Evaluate strategies for optimizing antibiotic use and combating resistance.

Main Methods:

  • Review of current literature on CAP pathogens and antibiotics.
  • Analysis of clinical trial data on monotherapy versus combination therapy.
  • Expert opinion on the efficacy of rapid treatment initiation and short-course therapy.

Main Results:

  • Discussion on the impact of new pathogens on CAP treatment selection.
  • Comparison of monotherapy and combination therapy approaches for CAP.
  • Assessment of the benefits of prompt treatment and shorter antibiotic courses.

Conclusions:

  • Updated treatment guidelines are crucial for effective CAP management.
  • Strategic use of antibiotics, including novel agents, is essential.
  • Antimicrobial stewardship, incorporating rapid and short-course therapy, can mitigate resistance.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...